@article{ee0395c55ae34185b9e6aac86e7b6439,
title = "A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing",
abstract = "Testing for polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene is still a standard part of thrombophilia testing in many laboratories. However, it is clear that these polymorphisms are not risk factors for arterial or venous thrombosis and therefore should not be part of thrombophilia testing. Eliminating MTHFR from thrombophilia testing will reduce patient concerns and health care costs.",
keywords = "MTHFR, guidelines, homocysteine, testing, thrombophilia",
author = "{The WTD Steering Committee} and Deloughery, {Thomas G.} and Hunt, {Beverley J.} and Barnes, {Geoffrey D.} and Connors, {Jean M.} and Cihan Ay and Stefano Barco and Lana Castellucci and Gabriela Cesarman-Maus and Paula, {Erich Vinicius De} and Mert Dumantepe and Esposito, {Maria Cecilia Guillermo} and Federica Fedele and Lee, {Lai Heng} and Claire McLintock and Eriko Morishita and Samama, {Charles Marc} and Helen Okoye and Todd Robertson",
note = "Publisher Copyright: {\textcopyright} 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).",
year = "2022",
month = may,
doi = "10.1002/rth2.12739",
language = "English (US)",
volume = "6",
journal = "Research and Practice in Thrombosis and Haemostasis",
issn = "2475-0379",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",
}